I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Zahir, Hamim
15
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Evaluation of Absorption and Metabolism-Based DDI Potential..:
Zahir, Hamim
;
Greenberg, Jonathan
;
Shuster, Dale
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652259/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
2
Pharmacokinetics of the Multi‐kinase Inhibitor Pexidartinib..:
Zahir, Hamim
;
Greenberg, Jonathan
;
Hsu, Ching
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099993/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
3
Phase I studies of the safety, tolerability, pharmacokineti..:
Maruyama, Sonomi
;
Visser, Hester
;
Ito, Takashi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010257/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
4
Exposure–response analysis of efficacy and safety for pexid..:
Yin, Ophelia
;
Zahir, Hamim
;
French, Jonathan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592513/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
5
Evaluation of Potential Drug‐Drug Interaction Risk of Pexid..:
Zahir, Hamim
;
Kobayashi, Fumiaki
;
Zamora, Cynthia
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891582/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
6
Population Pharmacokinetic Analysis of Pexidartinib in Heal..:
Yin, Ophelia
;
Wagner, Andrew J
;
Kang, Jia
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969430/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
7
Coadministration of probenecid and cimetidine with mirogaba..:
Tachibana, Masaya
;
Yamamura, Naotoshi
;
Atiee, George J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138503/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
8
Tolerability, pharmacokinetics, and pharmacodynamics of mir..:
Brown, Karen
;
Mendell, Jeanne
;
Ohwada, Shoichi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106189/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
9
Evaluation of the pharmacokinetic drug interaction potentia..:
Tachibana, Masaya
;
Papadopoulos, Kyriakos P
;
Strickler, John H
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736844/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
10
Edoxaban drug–drug interactions with ketoconazole, erythrom..:
Parasrampuria, Dolly A
;
Mendell, Jeanne
;
Shi, Minggao
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099547/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
11
Drug-Drug Interaction Studies of Cardiovascular Drugs Invol..:
Mendell, Jeanne
;
Zahir, Hamim
;
Matsushima, Nobuko
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781304. , 2013
Link:
http://www.ncbi.nlm.nih...
?
12
A Phase 1 Study of Efatutazone, an Oral Peroxisome Prolifer..:
Pishvaian, Michael J
;
Marshall, John L
;
Wagner, Andrew J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726261. , 2012
Link:
http://www.ncbi.nlm.nih...
?
13
Phase I studies of the safety, tolerability, pharmacokineti..:
Sonomi Maruyama
;
Hester Visser
;
Takashi Ito
...
https://doi.org/10.1111/cts.13214. , 2022
Link:
https://doi.org/10.1111/..
?
14
Exposure–response analysis of efficacy and safety for pexid..:
Ophelia Yin
;
Hamim Zahir
;
Jonathan French
...
https://doi.org/10.1002/psp4.12712. , 2021
Link:
https://doi.org/10.1002/..
?
15
Abuse potential of mirogabalin in recreational polydrug use..:
Jeanne Mendell
;
Naama Levy-Cooperman
;
Ed Sellers
...
https://doi.org/10.1177/2042098619836032. , 2019
Link:
https://doi.org/10.1177/..
1-15